Why Synapticure?

We believe tools to develop cures for neurodegenerative diseases are on the horizon. Our care is intentionally set up to remove barriers towards advancing those cures, from faster diagnosis to clinical trials support to data and research.

If you are interested in exploring research collaborations, Synapticure’s Research and Development Team can be contacted at partner@synapticure.com.

Synapticure’s lab team in Philadelphia

We help providers struggling to help their patients access a better model of care for complex neurodegenerative conditions

Specialist Access

Most PCPs are uneasy diagnosing and treating neurodegenerative diseases; >50% doctors in urban areas and >70% in rural areas describe a lack of access to neurodegenerative disease specialists

Immediate Care

Many communities face over a 6 months wait for specialists, losing valuable time to address symptoms, initiate disease-modifying treatments or enroll in clinical trials

In-network availability

Most patients and caregivers express a need for mental healthcare, but are unable to find providers who are in-network, available, and possess the right experience

Synapticure was founded by a patient and caregiver living with a neurodegenerative disease

With a care model designed by expert subspecialists with decades of experience and informed by the latest research.

Our mission is simple: improve access to personalized care that makes the experience of the disease less burdensome on patients, families and providers.

From bedside to bench and back to patients

We help providers struggling to help their patients access a better model of care for complex neurodegenerative conditions

Complete RWD at unique scale

- Complete
- Longitudinal
- Monthly engagements
- Diverse and National with no geographic restrictions

First virtual EAP offering

- Unique access for rural and underserved populations
- Rapid enrollment capability
- Remote collection and assessments

Consortium enabled for researching disease specifics

- IRB for ‘omics, bimonthly banking
- Presymptomatic studies
- Enabling ALL-ALS, other consortia

**Wet-lab developing best-in-class in vitro models**

- Unique, proprietary iPSC
-based model
- $3M raised in support of R&D (SBIR and philanthropy)
- Ongoing collaborations with half dozen industry partners

Publications & Presentations

Our work made the March 2023 cover of Stem Cell Reports
2023 mature organoid paper highlighted in Alzforum "In Organoids, Astrocytes prompt TDP-43 Pathology"
Webinar hosted by AxoSim for ALS month 2023
Clene MGB Webinar

How we partner

Support RWD projects
Support therapy access initiatives
Complex model validation for target validation, IND enablement, and candidate selection

Who we partner with

Primary Care Providers

Collaborative access to specialists and BH care for some of your most complex patients

ACOs

Improve medical expense management and close care gaps through a high quality, interdisciplinary care model proven to reduce acute care utilization, and delivered via telehealth

Health Systems

Create access to patients in underserved areas, align in-system care and improve performance on key outcome and quality measures

Neurology Clinics

Provide wraparound behavioral health and other services, while helping to drive clinical trial enrollment

Long Term Care Facilities

Integrate with on-site care teams to create specialty access, reducing the burden on staff and residents to travel for ongoing neurology care

Community Organizations and Home Care Providers

Your partner for quick access to clinical care, while helping existing patients and caregivers obtain and engage home-based services

How can we help?

Interested in learning more about Synapticure? Don’t hesitate to reach out. Our team will be in touch to learn more about your needs and discuss how we can work together to improve outcomes for your patients living with neurodegenerative diseases.

Why Synapticure?

We help providers struggling to help their patients access a better model of care for complex neurodegenerative conditions

Specialist Access

Immediate Care

In-network availability

Synapticure was founded by a patient and caregiver living with a neurodegenerative disease

From bedside to bench and back to patients

Complete RWD at unique scale

First virtual EAP offering

Consortium enabled for researching disease specifics

**Wet-lab developing best-in-class in vitro models**

Publications & Presentations

How we partner

Get in touch

Who we partner with

Primary Care Providers

ACOs

Health Systems

Neurology Clinics

Long Term Care Facilities

Community Organizations and Home Care Providers

How can we help?

It is time to leave behind the era of